NAPM/GPhA Merger Likely Ends Generic User Fees Push In 107th

The merger agreement between the National Association of Pharmaceutical Manufacturers and the Generic Pharmaceutical Association likely means generic drug user fees will not be a focal point of the PDUFA reauthorization process.